STOCK TITAN

Acreage Holding - ACRDF STOCK NEWS

Welcome to our dedicated page for Acreage Holding news (Ticker: ACRDF), a resource for investors and traders seeking the latest updates and insights on Acreage Holding stock.

About Acreage Holdings (OTCQX: ACRDF)

Acreage Holdings is a leading multi-state operator (MSO) in the U.S. cannabis industry, specializing in the cultivation, processing, and retailing of cannabis products. Founded in 2014, Acreage has built a vertically integrated business model that spans the entire cannabis supply chain, ensuring quality, consistency, and safety in its offerings. Operating under its flagship retail brand, The Botanist, and premium product brand, Superflux, Acreage serves both medical and adult-use cannabis markets across 11 states, including key markets such as Ohio, New Jersey, Illinois, and Connecticut.

Core Operations and Market Presence

Acreage's operations are strategically located in densely populated and high-growth states, allowing it to capitalize on the expanding cannabis market. With a focus on innovation, the company has introduced a diverse range of products, including fast-acting gummies, premium concentrates, and solventless vapes. Its retail presence is bolstered by The Botanist dispensaries, which provide a customer-centric experience emphasizing education, quality, and accessibility.

Industry Leadership and Partnerships

Acreage has established itself as a pioneer in the cannabis industry by fostering partnerships with regulators, medical professionals, and researchers. These collaborations aim to set new industry standards for product safety, dosability, and affordability. Furthermore, its integration with Canopy USA, a subsidiary of Canopy Growth Corporation, has enhanced its operational capabilities and brand synergies, positioning Acreage to leverage the rapidly growing U.S. cannabis market.

Growth Strategy and Competitive Edge

The company's growth strategy focuses on expanding its footprint, optimizing operations, and innovating its product portfolio. Recent milestones include the launch of non-medical cannabis sales in Ohio and the relocation of its New Jersey dispensary to Collingswood, marking the borough's first cannabis retail location. Acreage's emphasis on operational efficiency and its robust financial restructuring further strengthen its ability to navigate market challenges and seize growth opportunities.

Commitment to Quality and Compliance

Acreage is committed to maintaining the highest standards of quality and compliance in the cannabis industry. Its management team comprises veterans from retail, food and beverage, legal, and financial sectors, alongside cannabis cultivation experts who have shaped industry benchmarks. This diverse expertise ensures Acreage remains at the forefront of industry developments while adhering to evolving regulations.

Investment Considerations

As a vertically integrated MSO with a strong brand portfolio and strategic partnerships, Acreage Holdings is well-positioned to capitalize on the growing acceptance and legalization of cannabis in the U.S. Its focus on innovation, market expansion, and operational excellence underscores its potential for sustained growth in a competitive landscape.

Rhea-AI Summary

Acreage Holdings, a multi-state cannabis operator, announced a delay in releasing its fourth quarter (Q4 2022) and full year (FY 2022) financial results due to the need for additional time to complete financial statements and required disclosures. Consequently, the Company will not provide its financial results after market close on March 22, 2023, nor will it hold a conference call on March 23, 2023. An update regarding the financial reporting timeline will be provided in due course.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.42%
Tags
none
-
Rhea-AI Summary

Acreage Holdings has received a final order from the Supreme Court of British Columbia for its Floating Share Arrangement with Canopy Growth and Canopy USA. This arrangement allows Canopy USA to acquire all issued and outstanding Class D subordinate voting shares of Acreage at a ratio of 0.45 Canopy shares for each Floating Share. Additionally, Canopy plans to exercise its option under a prior agreement to acquire approximately 70% of Acreage's Class E shares at a set ratio. The agreement's completion hinges on meeting specific conditions, and an amendment has extended the deadline for conditions from March 31, 2023, to May 31, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.9%
Tags
none
-
Rhea-AI Summary

Acreage Holdings has announced that its Floating Shareholders voted in favor of a special arrangement with Canopy Growth Corporation during a meeting held on March 15, 2023. The arrangement will enable Canopy USA to acquire Acreage’s outstanding shares, consolidating Canopy's ownership of Acreage. CEO Peter Caldini emphasized the opportunity for shareholders to realize their investment's value in the evolving cannabis market. The arrangement requires court approval, with the final order hearing expected around March 20, 2023. Once approved, Canopy will hold full ownership of Acreage's shares, marking a significant milestone for the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.11%
Tags
none
Rhea-AI Summary

Acreage Holdings (OTCQX: ACRHF, ACRDF) announced a rescheduling of its Q4 2022 and FY 2022 financial results release to March 22, 2023, after market close. The accompanying conference call will take place at 10:00 a.m. ET on March 23, 2023. This delay is attributed to the complex disclosure process surrounding the Floating Share Arrangement with Canopy Growth Corporation, which diverted management resources from normal financial reporting tasks. This adjustment aims to ensure accurate financial disclosures.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.5%
Tags
-
Rhea-AI Summary

Acreage Holdings released a report highlighting that New York's current adult-use cannabis regulations create a significant retail bottleneck, which allows the illicit market to thrive. The report projects the state's legal cannabis market could be worth $5 - $7 billion, but limited legitimate retail access is stifling growth. Key findings reveal illicit operators could capture $7.2 billion in revenue from 2023 to 2030, resulting in a loss of 20,600 jobs annually and $2.6 billion in tax revenue over eight years. Acreage emphasizes the need to expand access for more operators to stabilize the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.5%
Tags
none
-
Rhea-AI Summary

Acreage Holdings, a U.S. cannabis operator, will report its financial results for Q4 and full year 2022 on March 14, 2023, post-market. The subsequent conference call is scheduled for March 15, 2023, at 10:00 a.m. ET, where management will discuss the results in detail. The company operates retail store brands like The Botanist and offers various cannabis products across the U.S. including hemp-derived CBD through its subsidiary Universal Hemp. This marks an important financial communication event for investors to follow Acreage’s performance amid evolving cannabis regulations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

Acreage Holdings announced the receipt of an interim order from the Supreme Court of British Columbia relating to its proposed Floating Share Arrangement with Canopy Growth Corporation, as detailed in its proxy statement filed with the SEC. The special meeting for Floating Shareholders is set for March 15, 2023, requiring a 66⅔% approval for the arrangement. Key conditions include obtaining final court approval and satisfying additional terms in the Arrangement Agreement. The voting deadline is March 13, 2023. Shareholders are encouraged to review the Circular for critical information and risk factors associated with this arrangement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.24%
Tags
none
-
Rhea-AI Summary

Acreage Holdings has launched its Fast-Acting Gummies, branded as The Botanist, in Illinois, Maine, Massachusetts, and Ohio. These gummies utilize the AZUCA TiME INFUSION™ technology, enabling effects to manifest in approximately 5-15 minutes, compared to the 1-4 hours typical of traditional edibles. Available in two flavors—Sparkling Orange and Sparkling Strawberry—each gummy contains either 5 mg or 10 mg of THC and is vegan and gluten-free. The product aims to meet the demand for quick-onset, enjoyable cannabis experiences, as stated by CEO Peter Caldini.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Acreage Holdings has launched adult-use cannabis operations at The Botanist dispensary in Montville, Connecticut, among the first in the state. The company anticipates the adult-use market will generate $375M in sales by 2023. CEO Peter Caldini emphasized the commitment to both adult and medical customers, ensuring high-quality service and inventory. The Botanist will prioritize medical patients with dedicated shopping features. A grand opening is set for today, featuring state officials, with more locations planned in Danbury and South Windsor later in 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.32%
Tags
none
Rhea-AI Summary

Acreage Holdings reported Q3 2022 consolidated revenue of $61.4 million, a 28% year-over-year increase. Adjusted EBITDA rose to $8.8 million, up 36% from Q3 2021. Gross margin decreased to 35% from 49% in Q3 2021, mainly due to inflation and competitive price pressures. Acreage concluded operations in Oregon and achieved adult-use sales in New Jersey. A strategic arrangement with Canopy Growth was announced to facilitate Canopy's acquisition of Acreage, promising future company growth. The company ended the quarter with $26.6 million in cash.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.58%
Tags

FAQ

What is the current stock price of Acreage Holding (ACRDF)?

The current stock price of Acreage Holding (ACRDF) is $0.122 as of February 7, 2025.

What is the market cap of Acreage Holding (ACRDF)?

The market cap of Acreage Holding (ACRDF) is approximately 5.0M.

What does Acreage Holdings do?

Acreage Holdings is a multi-state operator in the U.S. cannabis industry, focusing on cultivation, processing, and retailing cannabis products under brands like The Botanist and Superflux.

How does Acreage generate revenue?

Acreage generates revenue through its vertically integrated operations, including cannabis cultivation, processing, and retail sales across medical and adult-use markets.

What are Acreage’s key markets?

Acreage operates in 11 states, with key markets including Ohio, New Jersey, Illinois, and Connecticut, where it has a strong retail and cultivation presence.

What is Acreage’s relationship with Canopy Growth?

Acreage has integrated with Canopy USA, a subsidiary of Canopy Growth Corporation, enhancing its operational capabilities and market reach in the U.S.

What are Acreage’s flagship brands?

Acreage's flagship brands include The Botanist, known for its retail dispensaries, and Superflux, which offers premium cannabis products such as concentrates and edibles.

How is Acreage positioned in the cannabis industry?

Acreage is a vertically integrated operator with a strong market presence, innovative product portfolio, and strategic partnerships, positioning it as a key player in the evolving cannabis industry.

What challenges does Acreage face?

Acreage faces challenges such as regulatory hurdles, market competition, and liquidity constraints. However, its financial restructuring and operational efficiencies address these issues.

What is Acreage’s growth strategy?

Acreage focuses on market expansion, product innovation, and operational optimization to drive growth, with recent milestones including the launch of non-medical sales in Ohio.

What makes Acreage’s products unique?

Acreage emphasizes quality, safety, and dosability in its products, offering a diverse range of cannabis items, including fast-acting gummies, premium concentrates, and solventless vapes.

Why is Acreage significant to investors?

Acreage’s vertically integrated model, strong brand portfolio, and strategic partnerships with Canopy Growth position it for growth in the expanding U.S. cannabis market.
Acreage Holding

OTC:ACRDF

ACRDF Rankings

ACRDF Stock Data

4.97M
29.38M
13.76%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
New York